Literature DB >> 3378478

Permanent HBsAg clearance in chronic hepatitis B viral infection following acute delta superinfection.

K P Chin1, S Govindarajan, A G Redeker.   

Abstract

Three patients are described with chronic hepatitis B virus infection for three to six years before hepatitis delta virus superinfection occurred. Liver biopsy performed in two patients prior to their delta illness revealed chronic persistent hepatitis and chronic active hepatitis, respectively. Within one to seven months of the acute delta event, all three patients lost their circulating hepatitis B surface antigen. Subsequently, delta antibody also cleared. Clinical well-being and normal transaminases were documented over 10-44 months of follow-up. Although most cases of delta infection in chronic hepatitis B result in severe or progressive disease, a small number of patients may develop clearance of the HBsAg with clearance of both B and delta infections.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3378478     DOI: 10.1007/bf01550975

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  22 in total

1.  Long-lasting abatement of HBsAg synthesis induced by acute delta infection.

Authors:  D Frommel; J P Allain; A M Courouce; S Derose; D Trepo; O Crivelli; M Rizzetto
Journal:  Lancet       Date:  1983-03-19       Impact factor: 79.321

2.  Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis.

Authors:  J Rakela; A G Redeker; B Weliky
Journal:  Gastroenterology       Date:  1983-05       Impact factor: 22.682

3.  The significance of serologic, histologic, and immunohistologic findings in the prognosis of 88 asymptomatic carriers of hepatitis B surface antigen.

Authors:  H H Dormeyer; W Arnold; H Schönborn; B Braun; O Klinge; U Pfeifer; J Knolle; G Hess; P Kryger; J O Nielsen; K H Meyer zum Büschenfelde
Journal:  J Infect Dis       Date:  1981-07       Impact factor: 5.226

4.  Influence of delta infection on severity of hepatitis B.

Authors:  A Smedile; P Farci; G Verme; F Caredda; A Cargnel; N Caporaso; P Dentico; C Trepo; P Opolon; A Gimson; D Vergani; R Williams; M Rizzetto
Journal:  Lancet       Date:  1982-10-30       Impact factor: 79.321

5.  Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside.

Authors:  G H Scullard; R B Pollard; J L Smith; S L Sacks; P B Gregory; W S Robinson; T C Merigan
Journal:  J Infect Dis       Date:  1981-06       Impact factor: 5.226

6.  Transmission of the hepatitis B virus-associated delta antigen to chimpanzees.

Authors:  M Rizzetto; M G Canese; J L Gerin; W T London; D L Sly; R H Purcell
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

7.  Serum hepatitis B virus-DNA in chronic hepatitis B and delta infection.

Authors:  S Govindarajan; B Valinluck
Journal:  Arch Pathol Lab Med       Date:  1985-05       Impact factor: 5.534

8.  Hepatitis A infection in chronic carriers of hepatitis B virus.

Authors:  R Zachoval; M Roggendorf; F Deinhardt
Journal:  Hepatology       Date:  1983 Jul-Aug       Impact factor: 17.425

9.  Chronic asymptomatic HBSAg carriers: histologic abnormalities and diagnostic and prognostic value of serologic markers of the HBV.

Authors:  R De Franchis; A D'Arminio; M Vecchi; G Ronchi; E Del Ninno; A Parravicini; P Ferroni; A R Zanetti
Journal:  Gastroenterology       Date:  1980-09       Impact factor: 22.682

10.  Delayed HBsAg clearance in chronic hepatitis B viral infection.

Authors:  K L Lindsay; A G Redeker; M Ashcavai
Journal:  Hepatology       Date:  1981 Nov-Dec       Impact factor: 17.425

View more
  5 in total

1.  Acute delta hepatitis during treatment with adenosine arabinoside monophosphate with resolution of the HBsAg carrier state.

Authors:  G Garcia; A Smedile; K F Bergmann; J L Gerin; P B Gregory; T C Merigan; W S Robinson
Journal:  West J Med       Date:  1990-07

2.  Seroconversion of HBsAG coincides with hepatitis A super-infection: A case report.

Authors:  Claudia Beisel; Marylyn M Addo; Julian Schulze Zur Wiesch
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

3.  Hepatitis type C virus infection in patients with type B chronic liver disease.

Authors:  T Doi; G Yamada; H Endo; H Nishimoto; M Takahashi; R Miyamoto; S Fujiki; H Shimomura; M Mizuno; T Tsuji
Journal:  Gastroenterol Jpn       Date:  1992-10

Review 4.  Delta hepatitis: molecular biology and clinical and epidemiological features.

Authors:  L B Polish; M Gallagher; H A Fields; S C Hadler
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

Review 5.  HDV Pathogenesis: Unravelling Ariadne's Thread.

Authors:  Eirini D Tseligka; Sophie Clément; Francesco Negro
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.